Host cellular and extracellular biomolecules

Host cellular and extracellular biomolecules is a broad, non-specific classification used in pharmacological databases to describe the site of action for drugs that do not target a single, discrete molecular entity. This category encompasses a wide array of endogenous substances, including structural proteins, membrane lipids, and interstitial fluids, which may be affected by agents such as osmotic diuretics, topical antiseptics, or physical barriers (ChEMBL, 2024). Because the term covers the entire molecular landscape of the host, it lacks the specificity required for targeted drug design and is often used as a placeholder when a specific protein target is unknown or non-existent (ClinicalTrials.gov, 2024). Drugs interacting with these biomolecules typically exert their effects through physical properties or broad chemical reactivity rather than high-affinity binding to a specific pocket (NCBI, 2023). For example, agents like povidone-iodine or hydrogen peroxide act by non-specifically oxidizing various cellular components to achieve antimicrobial effects (PubChem, 2024). Similarly, osmotic agents like glycerin or hypertonic saline work by altering the physical environment of the extracellular space rather than binding to a receptor (StatPearls, 2024). Consequently, this classification is generally viewed as a catch-all term rather than a valid therapeutic target for precision medicine. The lack of specificity associated with this target often leads to a higher incidence of off-target effects and potential systemic toxicity if the agent is absorbed (PubMed, 2023).

Other names

Host biomoleculesCellular and extracellular componentsEndogenous biomolecules

Drugs targeting this broad category typically function through non-specific physical or chemical mechanisms, such as osmotic pressure modulation, oxidation of organic matter, or the creation of physical barriers, rather than through specific ligand-receptor binding (ChEMBL, 2024; PubChem, 2024).